I-Mab (IMAB) Stock Chart & Stock Price History $2.15 +0.05 (+2.38%) Closing price 04:00 PM EasternExtended Trading$2.16 +0.01 (+0.47%) As of 04:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock I-Mab Stock Price Performance The I-Mab (IMAB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 31.90%, with a year-to-date return of 152.94%. In the past month, the stock has decreased 14.68%, reflecting recent market activity. As of the latest close, I-Mab traded at $2.10 with a market cap of $171.49 million and volume of 102,717 shares. Five years ago, the stock traded at $32.64, representing a 93.41% decrease over that period. At the time, it had a market cap of $1.82 billion and a volume of 27,700 shares. Receive IMAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for I-Mab and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.94%1 Month Performance-14.68%3 Month Performance+155.56%Year-To-Date Performance+152.94%1 Year Performance+31.90%5 Year Performance-93.41% IMAB Stock Chart for Wednesday, July, 16, 2025 IMAB Chart by TradingView I-Mab Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/15/2025$2.14$2.10-1.87%$2.19$2.09102,717 shs$171.49 million07/14/2025$2.13$2.14+0.47%$2.18$2.06141,734 shs$174.75 million07/11/2025$2.05$2.13+3.90%$2.19$2.08224,260 shs$173.94 million07/10/2025$2.31$2.05-11.26%$2.37$2.05392,373 shs$167.40 million07/09/2025$2.20$2.31+5.00%$2.41$2.22371,502 shs$188.64 million07/08/2025$2.09$2.20+5.26%$2.25$2.10444,867 shs$179.65 million07/07/2025$2.23$2.09-6.28%$2.24$2.02351,396 shs$170.67 million07/04/2025$2.23$2.23$2.37$2.10358,562 shs$182.10 million07/03/2025$2.29$2.23-2.62%$2.37$2.10358,562 shs$182.10 million07/02/2025$2.34$2.29-2.14%$2.50$2.22485,354 shs$187.00 million Get the Latest News and Ratings for IMAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for I-Mab and its competitors with MarketBeat's FREE daily newsletter. 07/01/2025$2.42$2.34-3.31%$2.50$2.24453,641 shs$191.08 million06/30/2025$2.57$2.42-5.84%$2.74$2.34589,438 shs$197.62 million06/27/2025$2.02$2.57+27.23%$2.85$2.092.59 million shs$209.87 million06/26/2025$2.78$2.02-27.34%$2.95$2.001.83 million shs$164.95 million06/25/2025$2.37$2.78+17.30%$2.86$2.391.17 million shs$227.02 million06/24/2025$2.46$2.37-3.66%$2.54$2.35280,737 shs$193.53 million06/23/2025$2.50$2.46-1.60%$2.59$2.39354,719 shs$200.88 million06/20/2025$2.33$2.50+7.30%$2.55$2.33368,899 shs$204.15 million06/19/2025$2.33$2.33$2.47$2.29360,722 shs$190.27 million06/18/2025$2.47$2.33-5.67%$2.47$2.29360,722 shs$190.27 million06/17/2025$2.52$2.47-1.98%$2.69$2.40357,791 shs$201.70 million06/16/2025$2.49$2.52+1.20%$2.57$2.39510,297 shs$205.78 million Related Companies Maze Therapeutics Stock Price Chart Maravai LifeSciences Stock Price Chart Iovance Biotherapeutics Stock Price Chart Urogen Pharma Stock Price Chart Tilray Brands Stock Price Chart Tango Therapeutics Stock Price Chart Stoke Therapeutics Stock Price Chart Prime Medicine Stock Price Chart Dianthus Therapeutics Stock Price Chart Phathom Pharmaceuticals Stock Price Chart Receive IMAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for I-Mab and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IMAB) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s Little-Known Succession PlanYou could miss out on millions buying a house - even if prices rise Joel Litman is a millionaire member of ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding I-Mab Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share I-Mab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IMAB Stock Alerts